Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000032

Chief Scientific Officer disposed of 13,367,481 shares (other)

  • Chief Scientific Officer returned 523,926 shares (to the company)
  • Chief Scientific Officer acquired 8,230,453 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

NIGALAYE ASHOK G · Chief Scientific Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2013-04-25 Returned to the company : show line 1 in the form −150,000 $0.08 $12,000 22,510,022 I
2013-04-26 Returned to the company : show line 2 in the form −243,926 $0.08 $19,563 22,266,096 I
2013-04-26 Conversion : show line 3 in the form +8,230,453 30,496,549 I
2013-04-29 Returned to the company : show line 4 in the form −130,000 $0.08 $10,400 30,366,546 I
2013-04-29 Other disposition : show line 5 in the form −13,367,481 $0.04 $493,260 16,999,068 I

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2013-04-26 Conversion : show line 6 in the form Series E Convertible Preferred Stock −200 $1,000.00 $200,000 1,600 I
2013-04-26 Other disposition : show line 7 in the form Warrants −13,272,999 26,727,001 I
Loading xslF345X03/primary_doc.xml…